Clinical trial
Hydroxychloroquine in Giant Cell Arteritis
NCT00430807 · University Hospital, Toulouse, Other · Completed
Key facts
| NCT number | NCT00430807 |
|---|---|
| Title | Hydroxychloroquine in Giant Cell Arteritis |
| Official title | Multicentric Double Blind Versus Placebo Randomised Study Evaluating the Corticosteroid Sparing Effect of Hydrocyschloroquine in Non Complicated Giant Cell Arteritis. |
| Lead sponsor | University Hospital, Toulouse, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Giant Cell Arteritis |
| Intervention type | Drug |
| Interventions | hydroxychloroquine/placebo |
| Enrollment | 75 |
| Start date | Jan 1, 2002 |
| Primary completion | Jan 1, 2005 |
| Completion | Dec 1, 2006 |
| First posted | Feb 2, 2007 |
| Last update posted | Oct 6, 2015 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: